CRISPR gene editing represents a groundbreaking leap in modern science, enabling precise alterations to DNA that could revolutionize treatment for diseases like sickle cell disease.As researchers harness the power of this gene editing technology, they encounter not only the potential to cure debilitating ailments but also a host of ethical dilemmas, steeped in debates about CRISPR ethics and health equity.